Evidence map›Paper›PMID 33859207›Full record

ArticleNature communications2021

Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase.

Simon Bo Jensen, Sara Thodberg, Shaheena Parween, Matias E Moses, Cecilie C Hansen, Johannes Thomsen, Magnus B Sletfjerding, Camilla Knudsen, Rita Del Giudice, Philip M Lund and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pyridine indole hybrids as novel potent CYP17A1 inhibitors.Journal of enzyme inhibition and medicinal chemistry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Multifunctional Preprotein Binding Domain of SecA.Chembiochem : a European journal of chemical biology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Single-Particle Tracking ofBiomolecules · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Simon Bo JensenDepartment of Chemistry & Nanoscience Centre, University of Copenhagen, Copenhagen Ø, Denmark.ORCID http://orcid.org/0000-0002-8946-3831
Sara ThodbergPlant Biochemistry Laboratory, Department of Plant and Environmental Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-9332-6071
Shaheena ParweenPediatric Endocrinology, Diabetology, and Metabolism, University Children's Hospital, Bern, Switzerland.
Matias E MosesDepartment of Chemistry & Nanoscience Centre, University of Copenhagen, Copenhagen Ø, Denmark.ORCID http://orcid.org/0000-0001-8776-5302
Cecilie C HansenPlant Biochemistry Laboratory, Department of Plant and Environmental Sciences, University of Copenhagen, Copenhagen, Denmark.
Johannes ThomsenDepartment of Chemistry & Nanoscience Centre, University of Copenhagen, Copenhagen Ø, Denmark.ORCID http://orcid.org/0000-0002-0148-9114
Magnus B SletfjerdingDepartment of Chemistry & Nanoscience Centre, University of Copenhagen, Copenhagen Ø, Denmark.ORCID http://orcid.org/0000-0001-8669-4039
Camilla KnudsenPlant Biochemistry Laboratory, Department of Plant and Environmental Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-9573-5699
Rita Del GiudicePlant Biochemistry Laboratory, Department of Plant and Environmental Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-9927-9413
Philip M LundDepartment of Chemistry & Nanoscience Centre, University of Copenhagen, Copenhagen Ø, Denmark.ORCID http://orcid.org/0000-0001-5935-9753
Patricia R CastañoPediatric Endocrinology, Diabetology, and Metabolism, University Children's Hospital, Bern, Switzerland.
Yanet G BustamanteDepartment of Chemistry & Nanoscience Centre, University of Copenhagen, Copenhagen Ø, Denmark.ORCID http://orcid.org/0000-0001-6410-2514
Maria Natalia Rojas VelazquezPediatric Endocrinology, Diabetology, and Metabolism, University Children's Hospital, Bern, Switzerland.
Flemming Steen JørgensenDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen Ø, Denmark.ORCID http://orcid.org/0000-0001-8040-2998
Amit V PandeyPediatric Endocrinology, Diabetology, and Metabolism, University Children's Hospital, Bern, Switzerland.ORCID http://orcid.org/0000-0001-8331-5902
Tomas LaursenPlant Biochemistry Laboratory, Department of Plant and Environmental Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-6493-2259
Birger Lindberg MøllerPlant Biochemistry Laboratory, Department of Plant and Environmental Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-3252-3119
Nikos S HatzakisDepartment of Chemistry & Nanoscience Centre, University of Copenhagen, Copenhagen Ø, Denmark. hatzakis@chem.ku.dk.ORCID http://orcid.org/0000-0003-4202-0328
University of Copenhagen · DKUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic control is mediated by the dynamic assemblies and function of multiple redox enzymes. A key element in these assemblies, the P450 oxidoreductase (POR), donates electrons and selectively activates numerous (>50 in humans and >300 in plants) cytochromes P450 (CYPs) controlling metabolism of drugs, steroids and xenobiotics in humans and natural product biosynthesis in plants. The mechanisms underlying POR-mediated CYP metabolism remain poorly understood and to date no ligand binding has been described to regulate the specificity of POR. Here, using a combination of computational modeling and functional assays, we identify ligands that dock on POR and bias its specificity towards CYP redox partners, across mammal and plant kingdom. Single molecule FRET studies reveal ligand binding to alter POR conformational sampling, which results in biased activation of metabolic cascades in whole cell assays. We propose the model of biased metabolism, a mechanism akin to biased signaling of GPCRs, where ligand binding on POR stabilizes different conformational states that are linked to distinct metabolic outcomes. Biased metabolism may allow designing pathway-specific therapeutics or personalized food suppressing undesired, disease-related, metabolic pathways.

Indexed as

LigandsMetabolic Networks and PathwaysAromataseCell LineCytochrome P-450 Enzyme SystemEnzyme AssaysFluorescence Resonance Energy TransferHumansLiposomesMolecular Docking SimulationProtein BindingProtein Structure, TertiaryRecombinant ProteinsSingle Molecule ImagingSteroid 17-alpha-HydroxylaseSteroid 21-HydroxylaseAromataseCYP17A1 protein, humanCYP19A1 protein, humanCYP21A2 protein, humanCytochrome P-450 Enzyme SystemLigandsLiposomesPOR protein, humanRecombinant ProteinsSteroid 17-alpha-HydroxylaseSteroid 21-Hydroxylase

Identifiers

PMID33859207
PMCPMC8050233
OpenAlexW3153199601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.